ArticleBMC pulmonary medicine2024

Folate-modified liposomes mediate the co-delivery of cisplatin with miR-219a-5p for the targeted treatment of cisplatin-resistant lung cancer.

Yuanlin Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.